FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

Data Compilation
#PharmaFlow

Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

Stock Recap
#PipelineProspector

(R)-Tamsulosin Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

114 API Suppliers, 33 USDMF, 22 CEP/COS, 8 JDMF, 15 EU WC, 27 KDMF, 11 NDC API, 67 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

53 Drugs in Development

53 Drugs in Development

INTERMEDIATES

17 Intermediate Suppliers

17 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

476 FDF Dossiers, 21 FDA Orange Book, 306 Europe, 10 Canada, 26 Australia, 14 South Africa, 99 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.4MG, CAPSULE;ORAL - 0.5MG;0.4MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 13 Evonik, 1 Rochem International Inc, 4 SPI Pharma, 13 DKSH, 2 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 1 CD Formulation, 15 Corel Pharma Chem, 2 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 13 Ideal Cures, 2 Ingredion Pharma Solutions, 11 Kerry, 1 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem, 3 Vertellus

EXCIPIENTS BY APPLICATIONS

76 Coating Systems & Additives, 48 Fillers, Diluents & Binders, 46 Controlled & Modified Release, 32 Thickeners and Stabilizers, 31 Solubilizers, 22 Film Formers & Plasticizers, 21 Topical, 19 Direct Compression, 19 Lubricants & Glidants, 19 Taste Masking, 16 Granulation, 15 Parenteral, 11 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 8 Rheology Modifiers, 8 Disintegrants & Superdisintegrants, 7 Chewable & Orodispersible Aids, 5 Surfactant & Foaming Agents, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

14 News #PharmaBuzz

14 News #PharmaBuzz

GLOBAL SALES INFORMATION

20 US Medicaid Prescriptions, 65 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

29 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 USP, 5 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/01/2026	Swati Spentose	India	Samoh Pharmaceutical Co., Ltd.	20230921-209-J-1512	Tamsulosin hydrochloride	2023-09-21	Swati Spentose Private Limited (Unit-I)	India	Plot No. A-1/2102 & 2103 & A-2/2120, Phase III, GIDC, Vapi - 396 195 Dist : Valsad, Gujarat State India
29/01/2026	Astellas Pharma	Japan	Astellas Pharma Korea Co., Ltd.	20210426-209-J-956	Tamsulosin hydrochloride	2021-04-26	Astellas Pharma Inc. Takahagi Technology Center	Japan	160-2, Akahama, Takahagi-shi, Ibaraki 318-0001, Japan

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

(R)-Tamsulosin Hydrochloride

(R)-Tamsulosin Hydrochloride

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

114 API Suppliers

33 USDMF

22 CEP/COS

8 JDMF

15 EU WC

27 KDMF

11 NDC API

67 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

53 Drugs in Development

INTERMEDIATES

17 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

476 FDF Dossiers

21 FDA Orange Book

306 Europe

10 Canada

26 Australia

14 South Africa

99 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.4MG

CAPSULE;ORAL - 0.5MG;0.4MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

13 Evonik

1 Rochem International Inc

4 SPI Pharma

13 DKSH

2 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Kirsch Pharma

4 ACG Worldwide

8 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

23 BASF

1 CD Formulation

15 Corel Pharma Chem

2 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

3 Finar

10 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

13 Ideal Cures

2 Ingredion Pharma Solutions

11 Kerry

1 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

1 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

16 Roquette

14 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

2 Valens Pharmachem

3 Vasa Pharmachem

3 Vertellus